Noveris Health Sciences is trading at CA$1.36 (6.3% up) as the stock extends last week’s sharp volatility and short-term trading flows.

  • No new company-specific announcements, earnings, or regulatory filings have been identified for July 27.
  • The move appears driven by speculative interest in a thinly traded micro-cap stock, similar to the 10% gain noted on July 24.
  • Trading activity remains disconnected from fresh fundamentals and is characterized by high volatility and speculative momentum.